Skip to main content

Articles

Page 32 of 82

  1. Parkinson’s disease (PD) is the second most common neurodegenerative disease in the world. Various studies have suggested that the immune response plays a key role in this pathology. While a predominantly pro-...

    Authors: Diana D. Álvarez-Luquín, Asiel Arce-Sillas, Jaquelín Leyva-Hernández, Edgar Sevilla-Reyes, Marie Catherine Boll, Esteban Montes-Moratilla, Viridiana Vivas-Almazán, Citzielli Pérez-Correa, Ulises Rodríguez-Ortiz, Raquel Espinoza-Cárdenas, Gladis Fragoso, Edda Sciutto and Laura Adalid-Peralta
    Citation: Journal of Neuroinflammation 2019 16:212
  2. Bacterial infection is a potential risk factor for depression. However, little is known about the mechanistic link between bacterial endotoxin and depressive-like behaviors. The aim of the present study was to...

    Authors: Jia Zhao, Lixing Lao, Wei Cui and Jianhui Rong
    Citation: Journal of Neuroinflammation 2019 16:211
  3. The continuum of pro- and anti-inflammatory response elicited by traumatic brain injury (TBI) is suggested to play a key role in the outcome of TBI; however, the underlying mechanisms remain ill -defined.

    Authors: Elizabeth A. Kowalski, Jiang Chen, Amanda Hazy, Lauren E. Fritsch, Erwin Kristobal Gudenschwager-Basso, Michael Chen, Xia Wang, Yun Qian, Mingjun Zhou, Matthew Byerly, Alicia M. Pickrell, John B. Matson, Irving Coy Allen and Michelle H. Theus
    Citation: Journal of Neuroinflammation 2019 16:210
  4. Paclitaxel is a widely used and potent chemotherapeutic agent for the treatment of cancer. However, patients receiving paclitaxel often develop an acute pain syndrome for which there are few treatment options....

    Authors: Xiaojuan Liu, Raquel Tonello, Yuejuan Ling, Yong-Jing Gao and Temugin Berta
    Citation: Journal of Neuroinflammation 2019 16:209
  5. Microglial cells are activated in response to changes in brain homeostasis during aging, dementia, and stroke. Type 2 endocannabinoid receptors (CB2) and translocator protein 18 kD (TSPO) are considered to ref...

    Authors: Satoru Yamagishi, Yurika Iga, Masato Nakamura, Chika Takizawa, Dai Fukumoto, Takeharu Kakiuchi, Shingo Nishiyama, Hiroyuki Ohba, Hideo Tsukada, Kohji Sato and Yasuomi Ouchi
    Citation: Journal of Neuroinflammation 2019 16:208
  6. Neuropathic pain is often observed in individuals with multiple sclerosis (MS) and spinal cord injury (SCI) and is not adequately alleviated by current pharmacotherapies. A better understanding of underlying m...

    Authors: Ersilia Mirabelli, Li Ni, Lun Li, Cigdem Acioglu, Robert F. Heary and Stella Elkabes
    Citation: Journal of Neuroinflammation 2019 16:207
  7. Oligodendrocytes (OLs) death after spinal cord injury (SCI) contributes to demyelination, even leading to a permanent neurological deficit. Besides apoptosis, our previous study demonstrated that OLs underwent...

    Authors: Hong Fan, Hai-Bin Tang, Le-Qun Shan, Shi-Chang Liu, Da-Geng Huang, Xun Chen, Zhe Chen, Ming Yang, Xin-Hua Yin, Hao Yang and Ding-Jun Hao
    Citation: Journal of Neuroinflammation 2019 16:206
  8. Tick-borne encephalitis (TBE) is a severe neuropathological disorder caused by tick-borne encephalitis virus (TBEV). Brain TBEV infection is characterized by extensive pathological neuroinflammation. The mecha...

    Authors: Petra Pokorna Formanova, Martin Palus, Jiri Salat, Vaclav Hönig, Michal Stefanik, Pavel Svoboda and Daniel Ruzek
    Citation: Journal of Neuroinflammation 2019 16:205
  9. Chronic pain often occurs in the elderly, particularly in the patients with neurodegenerative disorders such as Alzheimer’s disease (AD). Although studies indicate that chronic pain correlates with cognitive d...

    Authors: Song Cao, Daniel W. Fisher, Tain Yu and Hongxin Dong
    Citation: Journal of Neuroinflammation 2019 16:204
  10. Retinal optical coherence tomography (OCT) is a clinical and research tool in multiple sclerosis, where it has shown significant retinal nerve fiber (RNFL) and ganglion cell (RGC) layer thinning, while postmor...

    Authors: Andrés Cruz-Herranz, Michael Dietrich, Alexander M. Hilla, Hao H. Yiu, Marc H. Levin, Christina Hecker, Andrea Issberner, Angelika Hallenberger, Christian Cordano, Klaus Lehmann-Horn, Lisanne J. Balk, Orhan Aktas, Jens Ingwersen, Charlotte von Gall, Hans-Peter Hartung, Scott S. Zamvil…
    Citation: Journal of Neuroinflammation 2019 16:203
  11. The thymus plays an essential role in the pathogenesis of myasthenia gravis (MG). In patients with MG, natural regulatory T cells (nTreg), a subpopulation of T cells that maintain tolerance to self-antigens, a...

    Authors: Peng Zhang, Ru-Tao Liu, Tong Du, Chun-Lin Yang, Yu-Dong Liu, Meng-Ru Ge, Min Zhang, Xiao-Li Li, Heng Li, Ying-Chun Dou and Rui-Sheng Duan
    Citation: Journal of Neuroinflammation 2019 16:202
  12. Patients with inflammatory bowel disease (IBD), including those with ulcerative colitis and Crohn’s disease, have higher rates of psychiatric disorders, such as depression and anxiety; however, the mechanism o...

    Authors: Kohei Takahashi, Osamu Nakagawasai, Wataru Nemoto, Takayo Odaira, Wakana Sakuma, Hiroshi Onogi, Hiroaki Nishijima, Ryuji Furihata, Yukio Nemoto, Hiroyuki Iwasa, Koichi Tan-No and Takeshi Tadano
    Citation: Journal of Neuroinflammation 2019 16:201
  13. Neuroinflammation can modulate brain development; however, the influence of an acute peripheral immune challenge on neuroinflammatory responses in the early postnatal brain is not well characterized. To addres...

    Authors: Matthew Bruce, Karin M. Streifel, Casey A. Boosalis, Luke Heuer, Eduardo A. González, Shuyang Li, Danielle J. Harvey, Pamela J. Lein and Judy Van de Water
    Citation: Journal of Neuroinflammation 2019 16:200
  14. Macrophage-derived high mobility group box 1 (HMGB1), a damage-associated molecular pattern (DAMP) protein, plays a key role in the development of chemotherapy-induced peripheral neuropathy (CIPN) caused by pa...

    Authors: Maho Tsubota, Ryotaro Fukuda, Yusuke Hayashi, Takaya Miyazaki, Shin Ueda, Rika Yamashita, Nene Koike, Fumiko Sekiguchi, Hidenori Wake, Shuji Wakatsuki, Yuka Ujiie, Toshiyuki Araki, Masahiro Nishibori and Atsufumi Kawabata
    Citation: Journal of Neuroinflammation 2019 16:199
  15. Epilepsy, a common multifactorial neurological disease, affects about 69 million people worldwide constituting nearly 1% of the world population. Despite decades of extensive research on understanding its unde...

    Authors: Chitra Rawat, Samiksha Kukal, Ujjwal Ranjan Dahiya and Ritushree Kukreti
    Citation: Journal of Neuroinflammation 2019 16:197
  16. The involvement of non-neuronal cells and the cells of innate immunity has been attributed to the initiation and progression of ALS. TDP-43 pathology is observed in a broad spectrum of ALS cases and is one of ...

    Authors: Javier H. Jara, Mukesh Gautam, Nuran Kocak, Edward F. Xie, Qinwen Mao, Eileen H. Bigio and P. Hande Özdinler
    Citation: Journal of Neuroinflammation 2019 16:196
  17. IL-10 knockout (KO) mice are protected from experimental autoimmune encephalomyelitis (EAE) with low-dose estrogen (E2) treatment similar to wild-type (WT) mice. Previous studies have demonstrated a decrease i...

    Authors: Hilary A. Seifert, Grant Gerstner, Gail Kent, Arthur A. Vandenbark and Halina Offner
    Citation: Journal of Neuroinflammation 2019 16:195
  18. Hypoxic-ischemic (HI) encephalopathy causes life-long morbidity and premature mortality in term neonates. Therapies in addition to whole-body cooling are under development to treat the neonate at risk for HI e...

    Authors: Nozha Borjini, Sandra Sivilia, Alessandro Giuliani, Mercedes Fernandez, Luciana Giardino, Fabrizio Facchinetti and Laura Calzà
    Citation: Journal of Neuroinflammation 2019 16:194
  19. Patients with pre-existing neurodegenerative disease commonly experience fractures that require orthopedic surgery. Perioperative neurocognitive disorders (PND), including delirium and postoperative cognitive ...

    Authors: Patrick Miller-Rhodes, Cuicui Kong, Gurpreet S. Baht, Priyanka Saminathan, Ramona M. Rodriguiz, William C. Wetsel, Harris A. Gelbard and Niccolò Terrando
    Citation: Journal of Neuroinflammation 2019 16:193
  20. Neuroinflammation and blood-brain barrier (BBB) disruption are two vital mechanisms of secondary brain injury following intracerebral hemorrhage (ICH). Recently, melanocortin-1 receptor (Mc1r) activation by Nl...

    Authors: Xuan Wu, Siming Fu, Yun Liu, Hansheng Luo, Feng Li, Yiying Wang, Meng Gao, Yuan Cheng and Zongyi Xie
    Citation: Journal of Neuroinflammation 2019 16:192
  21. Targeting angiogenesis has been and continues to be an attractive therapeutic modality in glioblastoma (GBM) patients. However, GBM rapidly becomes refractory to anti-VEGF therapies. Myeloid cell infiltration is ...

    Authors: Aurélie Soubéran, Sophie Brustlein, Caroline Gouarné, Lionel Chasson, Aurélie Tchoghandjian, Marie Malissen and Geneviève Rougon
    Citation: Journal of Neuroinflammation 2019 16:191
  22. The FDA-approved small-molecule drug dasatinib is currently used as a treatment for chronic myeloid leukemia (CML). However, the effects of dasatinib on microglial and/or astrocytic neuroinflammatory responses...

    Authors: Ka-Young Ryu, Hyun-ju Lee, Hanwoong Woo, Ri-Jin Kang, Kyung-Min Han, HyunHee Park, Sang Min Lee, Ju-Young Lee, Yoo Joo Jeong, Hyun-Wook Nam, Youngpyo Nam and Hyang-Sook Hoe
    Citation: Journal of Neuroinflammation 2019 16:190
  23. Prostatodynia is the main symptom of chronic prostatitis and the main reason that patients go to the hospital for treatment. Although a variety of factors, including inflammatory immune response, nervous syste...

    Authors: Guo-Chuang Deng, Ming Lu, Ya-Yu Zhao, Ying Yuan and Gang Chen
    Citation: Journal of Neuroinflammation 2019 16:189
  24. The glial response in multiple sclerosis (MS), especially for recruitment and differentiation of oligodendrocyte progenitor cells (OPCs), predicts the success of remyelination of MS plaques and return of funct...

    Authors: Tianci Chu, Yi Ping Zhang, Zhisen Tian, Chuyuan Ye, Mingming Zhu, Lisa B. E. Shields, Maiying Kong, Gregory N. Barnes, Christopher B. Shields and Jun Cai
    Citation: Journal of Neuroinflammation 2019 16:188
  25. The aryl hydrocarbon receptor (AHR) is a ligand-dependent transcription factor activated by environmental agonists and dietary tryptophan metabolites for the immune response and cell cycle regulation. Emerging...

    Authors: Wan-Ci Chen, Li-Hsin Chang, Shiang-Suo Huang, Yu-Jie Huang, Chun-Lien Chih, Hung-Chih Kuo, Yi-Hsuan Lee and I-Hui Lee
    Citation: Journal of Neuroinflammation 2019 16:187
  26. Blood markers indicative of neurodegeneration (neurofilament light chain; NFL), Alzheimer’s disease amyloid pathology (amyloid-β; Aβ), and neuroinflammation (kynurenine pathway; KP metabolites) have been inves...

    Authors: Pratishtha Chatterjee, Henrik Zetterberg, Kathryn Goozee, Chai K. Lim, Kelly R. Jacobs, Nicholas J. Ashton, Abdul Hye, Steve Pedrini, Hamid R. Sohrabi, Tejal Shah, Prita R. Asih, Preeti Dave, Kaikai Shen, Kevin Taddei, David B. Lovejoy, Gilles J. Guillemin…
    Citation: Journal of Neuroinflammation 2019 16:186
  27. Oxidative stress and vascular smooth muscle cell (VSMC) phenotypic modulation influence intracranial aneurysm (IA) formation and progression. Oxidative stress plays an important role in phenotype switching, an...

    Authors: Yuan Shi, Sichen Li, Yaying Song, Peixi Liu, Zixiao Yang, Yingjun Liu, Kai Quan, Guo Yu, Zhiyuan Fan and Wei Zhu
    Citation: Journal of Neuroinflammation 2019 16:185
  28. Glaucoma is a complex, multifactorial disease where apoptosis, microglia activation, and inflammation have been linked to the death of retinal ganglion cells (RGCs) and axon degeneration. We demonstrated previ...

    Authors: Anitha Krishnan, Andrew J. Kocab, David N. Zacks, Ann Marshak-Rothstein and Meredith Gregory-Ksander
    Citation: Journal of Neuroinflammation 2019 16:184
  29. Toll-like receptor 4 (TLR4) is well known for activating the innate immune system; however, it is also highly expressed in adaptive immune cells, such as CD4+ T-helper 17 (Th17) cells, which play a key role in mu...

    Authors: Xuebin Qu, Jingjing Han, Ying Zhang, Xingqi Wang, Hongbin Fan, Fang Hua and Ruiqin Yao
    Citation: Journal of Neuroinflammation 2019 16:183
  30. Since HIV-associated neurocognitive disorders (HANDs) occur in up to half of HIV-positive individuals, even with combined antiretroviral therapy (cART), adjunctive therapies are needed. Chronic CNS inflammatio...

    Authors: Christina Gavegnano, Woldeab B. Haile, Selwyn Hurwitz, Sijia Tao, Yong Jiang, Raymond F. Schinazi and William R. Tyor
    Citation: Journal of Neuroinflammation 2019 16:182
  31. Remote ischemic preconditioning (RIPC) initiates endogenous protective pathways in the brain from a distance and represents a new, promising paradigm in neuroprotection against cerebral ischemia-reperfusion (I...

    Authors: Weidong Liang, Chunshui Lin, Liuqing Yuan, Li Chen, Peipei Guo, Ping Li, Wei Wang and Xin Zhang
    Citation: Journal of Neuroinflammation 2019 16:181
  32. The endotoxin hypothesis of neurodegeneration is the hypothesis that endotoxin causes or contributes to neurodegeneration. Endotoxin is a lipopolysaccharide (LPS), constituting much of the outer membrane of gr...

    Authors: Guy C. Brown
    Citation: Journal of Neuroinflammation 2019 16:180
  33. We previously reported that Vδ2+Vγ9+ γδ T cells were significantly decreased in multiple sclerosis (MS) patients without disease-modifying therapies (untreated MS) and were negatively correlated with Expanded Dis...

    Authors: Guzailiayi Maimaitijiang, Mitsuru Watanabe, Koji Shinoda, Noriko Isobe, Yuri Nakamura, Katsuhisa Masaki, Takuya Matsushita, Yasunobu Yoshikai and Jun-ichi Kira
    Citation: Journal of Neuroinflammation 2019 16:179
  34. Ischemic stroke is the third cause of death in the developed countries and the main reason of severe disability. Brain ischemia leads to the production of damage-associated molecular patterns (DAMPs) by neuron...

    Authors: Sylwia Dabrowska, Anna Andrzejewska, Barbara Lukomska and Miroslaw Janowski
    Citation: Journal of Neuroinflammation 2019 16:178
  35. Until the end of the twentieth century, Zika virus (ZIKV) was thought to cause a mostly mild, self-limiting disease in humans. However, as the geographic distribution of ZIKV has shifted, so too has its pathog...

    Authors: Emina Hayashida, Zheng Lung Ling, Thomas M. Ashhurst, Barney Viengkhou, So Ri Jung, Pattama Songkhunawej, Phillip K. West, Nicholas J. C. King and Markus J. Hofer
    Citation: Journal of Neuroinflammation 2019 16:177
  36. Following publication of the original article [1], the authors opted to correct the following mistakes. According to the title and our results, the conclusions in the abstract and at the end of the discussion ...

    Authors: Tobias J. Krämer, Nathalia Hack, Till J. Brühl, Lutz Menzel, Regina Hummel, Eva-Verena Griemert, Matthias Klein, Serge C. Thal, Tobias Bopp and Michael K. E. Schäfer
    Citation: Journal of Neuroinflammation 2019 16:176

    The original article was published in Journal of Neuroinflammation 2019 16:163

  37. Regulation of neural inflammation is considered as a vital therapeutic target in ischemic stroke. All-trans retinoic acid (atRA), a potent immune modulator, has raised interest in the field of stroke therapy. ...

    Authors: Wei Cai, Julie Wang, Mengyan Hu, Xiao Chen, Zhengqi Lu, Joseph A. Bellanti and Song Guo Zheng
    Citation: Journal of Neuroinflammation 2019 16:175
  38. Oxidative stress, inflammation, and endoplasmic reticulum (ER) stress play a major role in the pathogenesis of neonatal hypoxic-ischemic (HI) injury. ER stress results in the accumulation of unfolded proteins ...

    Authors: Desislava Doycheva, Ningbo Xu, Jiping Tang and John Zhang
    Citation: Journal of Neuroinflammation 2019 16:174
  39. Disturbances in clock genes affect almost all patients with Alzheimer’s disease (AD), as evidenced by their altered sleep/wake cycle, thermoregulation, and exacerbation of cognitive impairment. As microglia-me...

    Authors: Junjun Ni, Zhou Wu, Jie Meng, Takashi Saito, Takaomi C. Saido, Hong Qing and Hiroshi Nakanishi
    Citation: Journal of Neuroinflammation 2019 16:173
  40. Systemic inflammation has been implicated in the progression of many neurodegenerative diseases and may be an important driver of the disease. Dementia and cognitive decline progress more rapidly following acu...

    Authors: Sarah K. Baker, Zu-Lin Chen, Erin H. Norris and Sidney Strickland
    Citation: Journal of Neuroinflammation 2019 16:172
  41. Age-related macular degeneration (AMD) is a multifactorial chronic disease of the eye. Several candidate pathways have been hypothesized to play a role in AMD pathogenesis. Our work and those of others suggest...

    Authors: Jiangyuan Gao, Jing Z. Cui, Aikun Wang, Hao Hang Rachel Chen, Alison Fong and Joanne A. Matsubara
    Citation: Journal of Neuroinflammation 2019 16:171
  42. Lysophosphatidic acid receptor 1 (LPA1) is in the spotlight because its synthetic antagonist has been under clinical trials for lung fibrosis and psoriasis. Targeting LPA1 might also be a therapeutic strategy for...

    Authors: Bhakta Prasad Gaire, Arjun Sapkota, Mi-Ryoung Song and Ji Woong Choi
    Citation: Journal of Neuroinflammation 2019 16:170
  43. Environmental factors are critical in the development of age-related cognitive decline and dementia. A western diet (WD) can cause nutrient deficiency and inflammation that could impact cognition directly. It ...

    Authors: Hongtian Yang, Leah C. Graham, Alaina M. Reagan, Weronika A. Grabowska, William H. Schott and Gareth R. Howell
    Citation: Journal of Neuroinflammation 2019 16:169
  44. Functions of astrocytes in the rehabilitation after ischemic stroke, especially their impacts on inflammatory processes, remain controversial. This study uncovered two phenotypes of astrocytes, of which one wa...

    Authors: Nan Zhao, Xiaomeng Xu, Yongjun Jiang, Jie Gao, Fang Wang, Xiaohui Xu, Zhuoyu Wen, Yi Xie, Juanji Li, Rongrong Li, Qiushi Lv, Qian Liu, Qiliang Dai, Xinfeng Liu and Gelin Xu
    Citation: Journal of Neuroinflammation 2019 16:168
  45. Although effective in reducing relapse rate and delaying progression, current therapies for multiple sclerosis (MS) do not completely halt disease progression. T cell autoimmunity to myelin antigens is conside...

    Authors: Judith Derdelinckx, María José Mansilla, Maxime De Laere, Wai-Ping Lee, Juan Navarro-Barriuso, Inez Wens, Irene Nkansah, Jasmijn Daans, Hans De Reu, Aneta Jolanta Keliris, Johan Van Audekerke, Verdi Vanreusel, Zoë Pieters, Annemie Van der Linden, Marleen Verhoye, Geert Molenberghs…
    Citation: Journal of Neuroinflammation 2019 16:167
  46. Currently, there are no effective therapeutic options for Alzheimer’s disease, the most common, multifactorial form of dementia, characterized by anomalous amyloid accumulation in the brain. Growing evidence p...

    Authors: Giulia Di Benedetto, Chiara Burgaletto, Anna R. Carta, Salvatore Saccone, Laurence Lempereur, Giovanna Mulas, Carla Loreto, Renato Bernardini and Giuseppina Cantarella
    Citation: Journal of Neuroinflammation 2019 16:166
  47. The association of gut microbiota and diseases of the central nervous system (CNS), including multiple sclerosis (MS), has attracted much attention. Although a previous analysis of MS gut microbiota revealed a...

    Authors: Tong Chen, Daisuke Noto, Yasunobu Hoshino, Miho Mizuno and Sachiko Miyake
    Citation: Journal of Neuroinflammation 2019 16:165
  48. Astrocytes respond to central nervous system (CNS) injury and disease by transforming to a reactive astrogliosis cell state that can contribute to either CNS dysfunction or repair. Neuroinflammation is a power...

    Authors: Qiong Zhou, Coralie Viollet, Anastasia Efthymiou, Guzal Khayrullina, Kasey E. Moritz, Matthew D. Wilkerson, Gauthaman Sukumar, Clifton L. Dalgard and Martin L. Doughty
    Citation: Journal of Neuroinflammation 2019 16:164
  49. The spectrum of classical and non-classical HLA genes related to the risk of multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) in the Japanese population has not been studied in detail...

    Authors: Kotaro Ogawa, Tatsusada Okuno, Kazuyoshi Hosomichi, Akiko Hosokawa, Jun Hirata, Ken Suzuki, Saori Sakaue, Makoto Kinoshita, Yoshihiro Asano, Katsuichi Miyamoto, Ituro Inoue, Susumu Kusunoki, Yukinori Okada and Hideki Mochizuki
    Citation: Journal of Neuroinflammation 2019 16:162

Annual Journal Metrics

  • 2022 Citation Impact
    9.3 - 2-year Impact Factor
    9.8 - 5-year Impact Factor
    1.792 - SNIP (Source Normalized Impact per Paper)
    2.439 - SJR (SCImago Journal Rank)

    2023 Speed
    12 days submission to first editorial decision for all manuscripts (Median)
    109 days submission to accept (Median)

    2023 Usage 
    3,039,907 downloads
    5,296 Altmetric mentions